is a new online resource designed to meet the evolving needs of physicians. It brings together elements from Advanstar's trusted healthcare journals along with powerful tools, resources, decision support and advisory functions.J. ChiAdvanstar Communications Inc...
Anthracycline extravasation gains new ICD-9-CM code CMS creates diagnosis code for extravasation therapy Going forward, hospital pharmacists will find it easier to get reimbursement for vesicant chemotherapy extravasation. The reason? The Centers for Medicare & Medicaid Services has set up ICD-9-CM ...
In addition, in vivo results on H19 knock-down mice indicate that H19 has a beneficial effect on the hypertrophic gene program and is useful in an anti-hypertrophic therapy (see FIGS. 34 and 35).In accordance with a preferred embodiment of the second aspect of the invention the cardiac hy...
Molecular Diagnosis & Therapy welcomes current opinion articles on emerging or contentious issues, comprehensive narrative reviews, systematic reviews (as outlined by the PRISMA statement), original research articles (including short communications) and letters to the editor. All manuscripts are subject to ...
The aftercare Z code should not be used if treatment is directed at a current, acute disease. The diagnosis code is to be used in these cases. Exceptions to this rule are codes Z51.0, Encounter for antineoplastic radiation therapy, and codes from subcategory Z51.1, Encounter for antineoplastic...
In mid-2006, the American Burn Association (ABA) began an initiative to revise ICD-9 subcategory code 695.1 (erythema multiforme [EM]) as the key first step toward two main goals: 1) to improve burn center reimbursement for toxic epidermal necrolysis syndrome (TENS) and Stevens-Johnson syndro...
Nanotechnology and Cancer Therapy Strategies Chapter © 2024 Nanomedicine in Targeted Drug Delivery: Precision Therapeutics for Personalized Medicine Chapter © 2024 1 Introduction The burgeoning field of nanomedicine has introduced an array of innovative strategies for the diagnosis and treatment of di...
Non-coding RNA Function Cancer Development Diagnosis Therapy 1. Introduction High-throughput technologies have allowed the discovery of RNA transcripts that do not encode for proteins, known as "non-coding RNA (ncRNAs)," which are ncRNAs in about 98% of the human genome after transcription [1]....
Furthermore, roughly 37% of patients were already prescribed oxygen at the time their coded IPF diagnosis, with 27% of those receiving oxygen having been prescribed this therapy for 4 or more years prior to their diagnosis. These observations further support the conclusion that the diagnosis of ...
However, it remains possible that tau will never become a successful target for AD therapy as it is more likely to be only a secondary effect to APP/Aβ pathology. 2.3 How to Manage Immunotherapies There is an ongoing debate regarding how the immunotherapies should be administered. One ...